Our Company Overview Investor Relations CareersPharma ServicesNeoGenomics offers lab services for oncology clinical trialsLearn moreCOVID-19Precision Medicine during this CrisisClick here to viewDONATE YOUR PLASMALatest Presented: September 2, 2020 Source: Webinar Launching a Companion Diagnostic Research & Development Through Commercialization Learn More Presented: August 19, 2020 Source: Webinar The Role of Liquid Biopsy Testing in Lung Cancer An overview of testing options for patients with NSCLC Learn More Image Published: August 11, 2020 Source: Article Is It Validated? NeoGenomics has a menu of >600 assays across many different technologies and approaches. Clients… Learn More Published: July 28, 2020 Source: Press Release NeoGenomics Reports Revenue of $87 Million in the Second Quarter amid COVID-19 Pandemic Learn More Published: July 20, 2020 Source: Press Release NeoGenomics Announces Board Appointments Learn More New Tests Image Available: September 28, 2020 Methodology: Immunohistochemistry (IHC) PIT1 PIT1 is a transcription factor critical in the normal development of the anterior pituitary. IHC… Learn More Image Available: September 23, 2020 Methodology: Molecular Full Focus Cancer Panel (Germline) Testing is performed by Fulgent Genetics. Patient and physician or genetic counselor signatures on… Learn More Image Available: September 2, 2020 Methodology: Immunohistochemistry (IHC) DLL3 Delta-like protein 3 (DLL3) expression is regulated by ASCL1, a transcription factor that is… Learn More Image Available: August 4, 2020 Methodology: FISH, Molecular NeoTYPE® Follicular Lymphoma Profile The NeoTYPE® Follicular Lymphoma Profile analyzes 15 genes through a combination of next-generation… Learn More Image Available: August 4, 2020 Methodology: FISH, Molecular NeoTYPE® Follicular Lymphoma Profile The NeoTYPE® Follicular Lymphoma Profile analyzes 15 genes through a combination of next-generation… Learn More
